170 related articles for article (PubMed ID: 38609521)
1. The best linear unbiased prediction (BLUP) method as a tool to estimate the lifetime risk of pancreatic ductal adenocarcinoma in high-risk individuals with no known pathogenic germline variants.
Cristina-Marianini-Rios ; Sanchez MEC; de Paredes AGG; Rodríguez M; Barreto E; López JV; Fuentes R; Beltrán MM; Sanjuanbenito A; Lobo E; Caminoa A; Ruz-Caracuel I; Durán SL; Olcina JRF; Blázquez J; Sequeros EV; Carrato A; Ávila JCM; Earl J
Fam Cancer; 2024 May; ():. PubMed ID: 38780705
[TBL] [Abstract][Full Text] [Related]
2. Twenty-five years of surveillance for familial and hereditary pancreatic ductal adenocarcinoma: Historical perspectives and introduction to the special issue.
Vasen HF; Canto MI; Goggins M
Fam Cancer; 2024 Jun; ():. PubMed ID: 38844715
[TBL] [Abstract][Full Text] [Related]
3. Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants.
Chen X; Meyer MA; Kemppainen JL; Horibe M; Chandra S; Majumder S; Petersen GM; Rabe KG
JAMA Oncol; 2023 Jul; 9(7):955-961. PubMed ID: 37200008
[TBL] [Abstract][Full Text] [Related]
4. Inherited predisposition to pancreatic cancer.
Hilfrank KJ; Rustgi SD; Kastrinos F
Semin Oncol; 2021 Feb; 48(1):2-9. PubMed ID: 33773812
[TBL] [Abstract][Full Text] [Related]
5. Understanding familial risk of pancreatic ductal adenocarcinoma.
Paranal RM; Wood LD; Klein AP; Roberts NJ
Fam Cancer; 2024 Apr; ():. PubMed ID: 38609521
[TBL] [Abstract][Full Text] [Related]
6. Germline sequence analysis of RABL3 in a large series of pancreatic ductal adenocarcinoma patients reveals no evidence of deleterious variants.
Roberts NJ; Grant RC; Gallinger S; Klein AP;
Genes Chromosomes Cancer; 2021 Aug; 60(8):559-564. PubMed ID: 33724601
[TBL] [Abstract][Full Text] [Related]
7. Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview.
Sikdar N; Saha G; Dutta A; Ghosh S; Shrikhande SV; Banerjee S
Curr Genomics; 2018 Sep; 19(6):444-463. PubMed ID: 30258276
[TBL] [Abstract][Full Text] [Related]
8. Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants.
Murali K; Dwarte TM; Nikfarjam M; Tucker KM; Vaughan RB; Efthymiou M; Collins A; Spigelman AD; Salmon L; Johns AL; Williams DB; Delatycki MB; John T; Stoita A
Hered Cancer Clin Pract; 2021 Aug; 19(1):33. PubMed ID: 34399810
[TBL] [Abstract][Full Text] [Related]
9. Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic
Overbeek KA; Rodríguez-Girondo MD; Wagner A; van der Stoep N; van den Akker PC; Oosterwijk JC; van Os TA; van der Kolk LE; Vasen HFA; Hes FJ; Cahen DL; Bruno MJ; Potjer TP
J Med Genet; 2021 Apr; 58(4):264-269. PubMed ID: 32482799
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancer.
Astiazaran-Symonds E; Goldstein AM
J Gastroenterol; 2021 Aug; 56(8):713-721. PubMed ID: 34255164
[TBL] [Abstract][Full Text] [Related]
11. Cancer statistics, 2023.
Siegel RL; Miller KD; Wagle NS; Jemal A
CA Cancer J Clin; 2023 Jan; 73(1):17-48. PubMed ID: 36633525
[TBL] [Abstract][Full Text] [Related]
12. Risk of Pancreatic Cancer in the Long-Term Prospective Follow-Up of Familial Pancreatic Cancer Kindreds.
Porter N; Laheru D; Lau B; He J; Zheng L; Narang A; Roberts NJ; Canto MI; Lennon AM; Goggins MG; Hruban RH; Klein AP
J Natl Cancer Inst; 2022 Dec; 114(12):1681-1688. PubMed ID: 36029239
[TBL] [Abstract][Full Text] [Related]
13. Incidence of Pancreatic Intraepithelial Neoplasia in an Autopsy Series.
Longnecker DS; Suriawinata AA
Pancreas; 2022 Apr; 51(4):305-309. PubMed ID: 35775638
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic Ductal Carcinoma Risk Associated With Hereditary Cancer-Risk Genes.
Gardiner A; Kidd J; Elias MC; Young K; Mabey B; Taherian N; Cummings S; Malafa M; Rosenthal E; Permuth JB
J Natl Cancer Inst; 2022 Jul; 114(7):996-1002. PubMed ID: 35445726
[TBL] [Abstract][Full Text] [Related]
15. Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants.
Momozawa Y; Sasai R; Usui Y; Shiraishi K; Iwasaki Y; Taniyama Y; Parsons MT; Mizukami K; Sekine Y; Hirata M; Kamatani Y; Endo M; Inai C; Takata S; Ito H; Kohno T; Matsuda K; Nakamura S; Sugano K; Yoshida T; Nakagawa H; Matsuo K; Murakami Y; Spurdle AB; Kubo M
JAMA Oncol; 2022 Jun; 8(6):871-878. PubMed ID: 35420638
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
